DK0991945T3 - Fremgangsmåde til identifikation af tumor-antigener med antistoffer i serum - Google Patents

Fremgangsmåde til identifikation af tumor-antigener med antistoffer i serum

Info

Publication number
DK0991945T3
DK0991945T3 DK98932884T DK98932884T DK0991945T3 DK 0991945 T3 DK0991945 T3 DK 0991945T3 DK 98932884 T DK98932884 T DK 98932884T DK 98932884 T DK98932884 T DK 98932884T DK 0991945 T3 DK0991945 T3 DK 0991945T3
Authority
DK
Denmark
Prior art keywords
protein antigens
sera
patients
identification
identified
Prior art date
Application number
DK98932884T
Other languages
English (en)
Other versions
DK0991945T4 (da
Inventor
Samir M Hanash
David Misek
Robert Hinderer
Latha Prasanan
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21967731&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0991945(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of DK0991945T3 publication Critical patent/DK0991945T3/da
Publication of DK0991945T4 publication Critical patent/DK0991945T4/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK98932884T 1997-06-26 1998-06-26 Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum DK0991945T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5083297P 1997-06-26 1997-06-26
PCT/US1998/013295 WO1999000671A2 (en) 1997-06-26 1998-06-26 Method for identification of tumor antigens with autoantibodies in serum

Publications (2)

Publication Number Publication Date
DK0991945T3 true DK0991945T3 (da) 2004-07-26
DK0991945T4 DK0991945T4 (da) 2008-06-09

Family

ID=21967731

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98932884T DK0991945T4 (da) 1997-06-26 1998-06-26 Fremgangsmåde til identifikation af tumor-antigener med autoantistoffer i serum

Country Status (9)

Country Link
EP (1) EP0991945B2 (da)
JP (2) JP4065574B2 (da)
AT (1) ATE266203T1 (da)
AU (1) AU8267398A (da)
CA (2) CA2294514C (da)
DE (1) DE69823660D1 (da)
DK (1) DK0991945T4 (da)
ES (1) ES2216295T5 (da)
WO (1) WO1999000671A2 (da)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2321160A1 (en) * 1998-02-13 1999-08-19 Oxford Glycosciences (Uk) Ltd. Methods and compositions for diagnosis of hepatoma
US6645465B2 (en) * 1999-08-06 2003-11-11 Michigan, University Of The Regents Annexin proteins and autoantibodies as serum markers for cancer
US6306615B1 (en) * 1999-08-19 2001-10-23 Tularik Inc. Detection method for monitoring β tubulin isotype specific modification
US7214498B2 (en) 2001-03-23 2007-05-08 Benaroya Research Institute At Virginia Mason Tumor associated antigens and methods of using the same
DE10151051B4 (de) * 2001-09-14 2007-07-12 Zeidler, Reinhard, Dr. Identifizierung von Antigenen durch xenogene, allogene oder autologe Antikörper-vermittelte Präzipitation
US20050221305A1 (en) * 2001-11-09 2005-10-06 Benaroya Research Institute At Virginia Mason Antigen panels and methods of using the same
GB2424273B (en) * 2002-11-14 2007-06-27 Univ Nottingham Method for preparing tumour marker protein
AU2003903317A0 (en) * 2003-06-27 2003-07-10 Proteome Systems Intellectual Property Pty Ltd Method of isolating a protein
BRPI0619712A2 (pt) * 2005-11-10 2011-10-11 Univ Kentucky dispositivo para a identificação de um paciente como um candidato para testes radiográficos para o cáncer do pulmão, composição para detectar radiograficamente um cáncer do pulmão de estágio adiantado, dispositivo para o ensaio do cáncer do pulmão, uso de um painel, e, dispositivo de diagnóstico para a detecção do cáncer do pulmão
CN101490550A (zh) * 2006-07-08 2009-07-22 肯塔基大学研究基金会 肺癌诊断分析
JP2011107064A (ja) * 2009-11-20 2011-06-02 Nitto Boseki Co Ltd クラスリン重鎖に対する自己抗体の免疫測定方法、それに用いるキット、及びそれを用いた癌判定方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2062675A1 (en) * 1991-04-09 1992-10-10 Sandra S. Fenton Endometrial antigen, composition, test kit and method for endometrial antibody determination
US5405749A (en) * 1991-12-06 1995-04-11 Polans; Arthur S. Method for identifying and purifying a cancer associated retinopathy autoantigen, and testing patient serum for the autoantibody to the autoantigen
WO1994028021A1 (en) * 1993-05-28 1994-12-08 Medical University Of South Carolina Endometrial proteins, antigenic compositions and methods for detecting endometriosis

Also Published As

Publication number Publication date
CA2665707C (en) 2013-02-12
DE69823660D1 (de) 2004-06-09
ES2216295T3 (es) 2004-10-16
CA2294514A1 (en) 1999-01-07
EP0991945A2 (en) 2000-04-12
DK0991945T4 (da) 2008-06-09
CA2665707A1 (en) 1999-01-07
EP0991945B1 (en) 2004-05-06
WO1999000671A2 (en) 1999-01-07
EP0991945B2 (en) 2008-02-20
AU8267398A (en) 1999-01-19
ATE266203T1 (de) 2004-05-15
WO1999000671A3 (en) 1999-06-10
ES2216295T5 (es) 2008-06-01
JP2007333744A (ja) 2007-12-27
CA2294514C (en) 2009-09-01
JP2002508835A (ja) 2002-03-19
JP4065574B2 (ja) 2008-03-26

Similar Documents

Publication Publication Date Title
BR0208603A (pt) Marcadores de tumor para carcinoma de células renais
EP1734368B1 (en) Annexin autoantibodies used as markers for lung cancer
CY1112631T1 (el) ΜΕΘΟΔΟΙ ΤΑΥΤΟΠΟΙΗΣΗΣ ΟΓΚΩΝ ΠΟΥ ΑΠΟΚΡΙΝΟΝΤΑΙ ΣΕ ΑΓΩΓΗ ΜΕ ΑΝΤΙΣΩΜΑΤΑ ΑΝΤΙ-ΕrbB2
Canelle et al. An efficient proteomics-based approach for the screening of autoantibodies
DE69929185D1 (de) Tumormarker
CY1108450T1 (el) Μεθοδος για την ανιχνευση ν-τελικου προβνρ
DE69735294D1 (de) Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
TR200200937T2 (tr) Yumurtalık kanseri tedavisi için bileşimler.
DE69839123D1 (de) Prostattumor polynukleotid- und antigenzusammensetzungen
DK0991945T3 (da) Fremgangsmåde til identifikation af tumor-antigener med antistoffer i serum
Zhou et al. Antibodies to peptides in semiconserved domains of RIFINs and STEVORs correlate with malaria exposure
IL142971A0 (en) S100 proteins and autoantibodies as serum markers for cancer
DE3780480D1 (de) Test fuer menschlichen brustkrebs.
ES2121358T3 (es) Anticuerpos monoclonales humanizados contra interleuquina-4 humana.
KR830003898A (ko) 인체 암 핵인 항원에 대한 항체를 사용한 인체 암세포의 검출
WO2008099419A3 (en) Autoantibodies for protein antigens as markers for cancer of gingivo-buccal complex
NO168311C (no) Monoklonale antistoffer for humane ikke-smaacelle lungekarsinomer, cellelinjer som produserer disse samt diagnostisksett
Kennel Characterization of a tumor cell surface protein with heterologous antisera to a spontaneous BALB/c lung carcinoma
ATE192236T1 (de) Menschliche phospholipase aktivierender proteinteil
FI20010868A0 (fi) Menetelmä ja välineet gluteenin indusoimien tautien havaitsemiseksi
DK102589A (da) Antigen, der genkendes af mca 16-88
DE69119591D1 (de) Das von mca-28a32 erkannte antigen
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
CA2264963A1 (en) Protein markers for esophageal cancer
Evans et al. Biochemical and physical characterizations of tumor-associated fetal antigens